Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in BIOMARIN PHARMACEUTICAL INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 638,725 shares of BMRN (BIOMARIN PHARMACEUTICAL INC), worth $38M as of 2025-Q4. The position was decreased (-40.5% shares). BMRN represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$38M
Current Shares
638,725
Total Value Change
-$45.4M
Total Shares Change
-374,315
Other major holders of BMRN: BNP PARIBAS FINANCIAL MARKETS, DnB Asset Management AS
Decreased |
| 638,725 |
-40.5% |
| $38M |
| 0.0% |
| $58.99 |
0 |
| 2025-Q3 | Decreased | 1.1M | -18.6% | $58.2M | 0.0% | $54.02 | 0 |
| 2025-Q2 | Increased | 1.3M | +23.9% | $72.5M | 0.0% | $55.17 | 36 |
| 2025-Q1 | Increased | 1.1M | +0.9% | $75.3M | 0.0% | $71.44 | 30 |
| 2024-Q4 | Increased | 1.1M | +19.8% | $69.4M | 0.0% | $65.45 | 35 |
| 2024-Q3 | Decreased | 880,453 | -13.1% | $61.9M | 0.0% | $70.58 | 0 |
| 2024-Q2 | Increased | 1M | +36.0% | $83.4M | 0.0% | $82.33 | 39 |